Clinical studies have shown that tirzepatide: Significantly reduces hemoglobin A1C levels compared to placebo Promotes weight loss in a dose-dependent manner May have potential benefits for non-alcoholic fatty liver disease (NAFLD) patients Tirzepatide is typically administered as follows: Once-weekly subcutaneous injection Available in various strengths (e.g., 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) Dose is usually titrated over time to reach the target dose Common side effects may include: Nausea Diarrhea Decreased appetite Vomiting Constipation Abdominal pain Tirzepatide should be used with caution in patients with: History of pancreatitis Severe gastrointestinal disease Diabetic retinopathy Pregnancy: Tirzepatide should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus
Approval is not automatic or algorithmic and requires individualized clinician review
I'm lifting at least three days a week, trying to get a cardio session or two in on days I'm not strength training, keeping my protein intake at a higher level, and maintaining hydration - water can be a huge help in feeling full
Dehydration caused by severe vomiting or diarrhea may induce kidney damage, and patients with renal impairment should be monitored closely
Among these, muscle pain has been reported by some users, raising questions about its frequency, severity, and underlying causes
When troche or liquid is used, the medication is absorbed in the mouth and lower doses can be used